Quadramet (Lantheus Medical Imaging, Inc.)
Welcome to the PulseAid listing for the Quadramet drug offered from Lantheus Medical Imaging, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Lantheus Medical Imaging, Inc. |
| NON-PROPRIETARY NAME: | samarium Sm 153 lexidronam |
| SUBSTANCE NAME: | SAMARIUM SM-153 LEXIDRONAM PENTASODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1997-05-19 |
| END MARKETING DATE: | 0000-00-00 |
Quadramet HUMAN PRESCRIPTION DRUG Details:
| Item Description | Quadramet from Lantheus Medical Imaging, Inc. |
| LABELER NAME: | Lantheus Medical Imaging, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mCi/mL) |
| START MARKETING DATE: | 1997-05-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 11994-016_fb28f955-edfe-43b6-bdf2-04149bf0dc5a |
| PRODUCT NDC: | 11994-016 |
| APPLICATION NUMBER: | NDA020570 |
Other SAMARIUM SM-153 LEXIDRONAM PENTASODIUM Pharmaceutical Manufacturers / Labelers:
